The Challenge of Change - Managing Excipients Control
Colorcon
11-Oct-2011 - AstraZeneca has broken ground on a $200m (€147m) manufacturing facility in China to meet soaring demand in the country.
11-Oct-2011 - Sanofi Pasteur says it will regain lost ground in India through its new state-of-the-art vaccine manufacturing plant.
10-Oct-2011 - Medecins Sans Frontieres (MSF) wants Brazil to streamline its validation process for the API benznidazole after global stocks of the Chagas disease treatment drop to critical levels.
10-Oct-2011 - Ugandan drugs maker Quality Chemical Industries Ltd (QCIL) is ready to manufacture HIV treatment Tenofovir in a bid to dominate the local antiretroviral market.
10-Oct-2011 - iBio is expanding use of its green plant technology to biosimilar mAbs after producing rituximab using the system.
10-Oct-2011 - Akorn is doubling capacity and hiring “as fast as [it] can” after drug shortages sent demand for its injectables soaring.
06-Oct-2011 - Vetter says it will reduce API wastage through its new US production facility for the filling of syringes, cartridges and vials.
06-Oct-2011 - Avacta has allied with Pall to offer biopharm manufacturers in Singapore and South Korea tools to assess formulation viability.
05-Oct-2011 - Active pharmaceutical ingredient (API) manufacturer ScinoPharm has gone public in a bid to raise funds for its upcoming expansions.
05-Oct-2011 - Solvias and RohnerChem have set up a research and manufacturing services partnership designed to accelerate the production, scale-up and commercialisation of APIs.
05-Oct-2011 - The FDA has awarded a $35m (€26m) grant to make US drug production less expensive and reverse the offshoring trend.
04-Oct-2011 - Roche has opened the doors to its new center of excellence supply manufacturing facility in New Jersey, US.
03-Oct-2011 - CDMO Aesica is to add manufacturing capacity in Asia and the US following a cash injection from private equity firm Silverfleet Capital.
03-Oct-2011 - SAFC will extend its focus on high potency production through a number of new investments.
03-Oct-2011 - The Australian TGA is seeking benzylpenicillin manufacturers after CSL warned that its supplier, Sandoz, is unable to meet global demand.
28-Sep-2011 - The fall-out from Genzyme’s supply disruptions is still hindering Sanofi, more than five months after taking over the business.
28-Sep-2011 - Lonza may build a stem cell production facility dedicated to manufacturing Mesoblast products after inking an alliance.
27-Sep-2011 - Peptide-based therapeutics specialists Unigene will focus on high valuation drug development and drug delivery opportunities after cutting loose its Site Directed Bone Growth (SDBG) patent portfolio.
27-Sep-2011 - Cambridge Major Laboratories Europe (CMLE) is set to start commercial API manufacturing at its facility in the Netherlands after approval by Dutch regulators.
22-Sep-2011 - Oxford Pharmascience expects the challenges facing biopharm to drive interest in its drug delivery and reformulation technologies.
21-Sep-2011 - SAFC is putting special focus on supply chain and quality management as part of its new strategic plan.
21-Sep-2011 - Rx-360 has begun its audit sharing programme to increase knowledge about suppliers and the quality of pharmaceutical raw materials.
20-Sep-2011 - The FDA is targeting companies that reformulate drugs to evade enforcement as it tries to crackdown on the 1000s of products marketed without approval.
20-Sep-2011 - Chemicals supplier Lubrizol was bought by Warren Buffet’s Berkshire Hathaway group last week in a deal worth $9.7bn (€7.1bn)
19-Sep-2011 - Alkermes has celebrated the launch of its new Irish drug delivery and formulation business by winning a new multimillion dollar manufacturing contract with a ‘top 10 pharma.’